Advances in the Drugs Treatment of Psoriatic Arthritis by LU Chaofan, LENG Xiaomei

Subjects: “…conventional synthetic disease-modifying antirheumatic drugs…”
Get full text

Current issues in the management of patients with HIV infection and rheumatic diseases by G. I. Gridneva, B. S. Belov

Subjects: Get full text

Incident and recurrent herpes zoster for first-line bDMARD and tsDMARD users in seropositive rheumatoid arthritis patients: a nationwide cohort study by Seogsong Jeong, Seulggie Choi, Sang Min Park, Jinseok Kim, Byeongzu Ghang, Eun Young Lee

Subjects: “…Biologic disease-modifying antirheumatic drugs…”
Get full text

Targeted Therapy for Rheumatoid Arthritis in the New Era by WANG Jun, MENG Juan

Subjects: “…biologic disease-modifying antirheumatic drugs…”
Get full text

Pharmacoeconomic study of active psoriatic arthritis treatment by A. V. Rudakova, Т. V. Korotaeva

Subjects: “…biological disease-modifying antirheumatic drugs…”
Get full text

Peculiarities of pharmacotherapy of patients with rheumatoid arthritis associated with interstitial lung disease by A. V. Gordeev, E. A. Galushko, E. V. Matyanova, E. V. Pozhidaev, E. G. Zotkin, A. M. Lila

Subjects: Get full text

Comparison of treatment of severe rheumatoid arthritis patients with biological agents and JAK-STAT inhibitors. An extension study by Małgorzata Wisłowska

Subjects: “…biological disease modifying antirheumatic drugs (bdmards)…”
Get full text

Treatment adherence to disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis by Xia Y, Yin R, Fu T, Zhang L, Zhang Q, Guo G, Li L, Gu Z

Subjects: Get full text

Disease-modifying antirheumatic drugs – Old and new: A brief overview by Vidya Divakar Baliga, Raghuveer S Prabhu

Subjects: Get full text

Difficult-to-treat rheumatoid arthritis in the clinical practice of a rheumatological hospital. First look by A. V. Gordeev, E. V. Matyanova, Yu. A. Olyunin, E. A. Galushko, E. G. Zotkin

Subjects: Get full text

Reduction in the need for glucocorticoids on the background of therapy with biologic disease-modifying antirheumatic drugs and Janus kinase inhibitors in rheumatoid arthritis: evid... by Alena S. Potapova, Andrey E. Karateev, Elena Yu. Polishchuk, Ekaterina S. Filatova, Vera N. Amirdzhanova, Aleksander M. Lila

Subjects: Get full text

NEW GUIDELINES FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS (EULAR, 2013): THE PLACE OF GLUCOCORTICOIDS by E. L. Nasonov

Subjects: “…disease-modifying antirheumatic drugs…”
Get full text

Factors influencing use of biologic therapy and adoption of treat-to-target recommendations in current European rheumatology practice by Taylor PC, Alten R, Gomez Reino JJ, Caporali R, Bertin P, Sullivan E, Wood R, Piercy J, Vasilescu R, Spurden D, Alvir J, Tarallo M

Subjects: Get full text

NEW GUIDELINES FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS (EULAR, 2013): THE PLACE OF GLUCOCORTICOIDS by E. L. Nasonov

Subjects: “…disease-modifying antirheumatic drugs…”
Get full text

NEW GUIDELINES FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS (EULAR, 2013): THE PLACE OF GLUCOCORTICOIDS by E. L. Nasonov

Subjects: “…disease-modifying antirheumatic drugs…”
Get full text

Serum IL-40 increases in patients with rheumatoid arthritis and correlates with some clinical characteristics and comorbidities by Wei Wang, Juan Zhao, Siyu Wu, Jinfang Fu, Yunli Zhang, Wanchan Peng

Subjects: Get full text

COVID-19 and post-covid syndrome in patients with rheumatoid arthritis by E. S. Aronova, B. S. Belov, G. I. Gridneva

Subjects: Get full text

Experience of guselkumab usage in the treatment of patients with psoriatic arthritis in real clinical practice by E. Yu. Loginova, Yu. L. Korsakova, T. V. Korotaeva

Subjects: “…biologic disease modifying antirheumatic drugs…”
Get full text

GLUCOCORTICOIDS AND RHEUMATOID ARTHRITIS by Zhdan V. M., Volchenko H. V., Babanina M. Y., Tkachenko M. V., Khaimenova H. S.

Subjects: Get full text

Comparison of the efficacy and safety of methotrexate alone or in combination with leflunomide in the treatment of juvenile idiopathic arthritis: a double-blind, placebo-controlled... by Zahra Rezaieyazdi, Sahar Ravanshad, Mandana Khodashahi, Maliheh Bokaeian, Hassan Mehrad Majd, Masoumeh Salari

Subjects: Get full text